论文部分内容阅读
选取在2013年3月~2015年3月期间146例口服降糖药不理想的2型糖尿病患者,随机分为观察和对照组,每组73例,两组患者注射甘精胰岛素,观察组再加空腹口服格列美脲,12周。结果:治疗前后两组的血糖水平有显著差异(P<0.05);观察组低于对照组(P<0.05);观察组总有效率为91.78%,显著高于对照组的79.45%(P<0.05)。结论:甘精胰岛素联合格列美脲法治疗2型糖尿病临床疗效显著。
A total of 146 patients with type 2 diabetes who did not receive oral hypoglycemic agents during the period from March 2013 to March 2015 were randomly divided into observation and control group, 73 cases in each group. Patients in both groups were given insulin glargine, Plus fasting oral glimepiride, 12 weeks. Results: The blood glucose level of the two groups before and after treatment were significantly different (P <0.05), the observation group was lower than the control group (P <0.05). The total effective rate was 91.78% in the observation group, which was significantly higher than 79.45% in the control group (P < 0.05). Conclusion: Glargine and glimepiride treatment of type 2 diabetes clinical significant effect.